statistiche ricercatore

Continente	#
AS - Asia	395
NA - Nord America	353
EU - Europa	309
SA - Sud America	116
AF - Africa	105
OC - Oceania	4
Continente sconosciuto - Info sul continente non disponibili	3
Totale	1.285

Nazione	#
US - Stati Uniti d'America	303
SG - Singapore	150
IT - Italia	118
BR - Brasile	82
HK - Hong Kong	79
CN - Cina	61
GB - Regno Unito	25
FI - Finlandia	23
DE - Germania	21
NL - Olanda	17
PL - Polonia	15
BJ - Benin	11
AR - Argentina	9
FR - Francia	9
IN - India	8
KR - Corea	8
RU - Federazione Russa	8
ZA - Sudafrica	8
JP - Giappone	7
VN - Vietnam	7
CA - Canada	6
EC - Ecuador	6
RO - Romania	6
SE - Svezia	6
UA - Ucraina	6
AT - Austria	5
BD - Bangladesh	5
BF - Burkina Faso	5
CM - Camerun	5
CO - Colombia	5
HU - Ungheria	5
ID - Indonesia	5
LY - Libia	5
MX - Messico	5
PS - Palestinian Territory	5
TR - Turchia	5
AZ - Azerbaigian	4
BY - Bielorussia	4
CZ - Repubblica Ceca	4
GH - Ghana	4
JM - Giamaica	4
LA - Repubblica Popolare Democratica del Laos	4
ML - Mali	4
MZ - Mozambico	4
NI - Nicaragua	4
AE - Emirati Arabi Uniti	3
AL - Albania	3
AM - Armenia	3
CD - Congo	3
GE - Georgia	3
GF - Guiana Francese	3
GN - Guinea	3
HN - Honduras	3
IS - Islanda	3
JO - Giordania	3
KH - Cambogia	3
MD - Moldavia	3
MW - Malawi	3
MY - Malesia	3
PA - Panama	3
PH - Filippine	3
PR - Porto Rico	3
PY - Paraguay	3
SO - Somalia	3
TH - Thailandia	3
TN - Tunisia	3
TZ - Tanzania	3
VE - Venezuela	3
YE - Yemen	3
ZW - Zimbabwe	3
AD - Andorra	2
AO - Angola	2
BA - Bosnia-Erzegovina	2
BE - Belgio	2
BO - Bolivia	2
BS - Bahamas	2
CV - Capo Verde	2
DJ - Gibuti	2
DK - Danimarca	2
DZ - Algeria	2
EE - Estonia	2
EG - Egitto	2
ET - Etiopia	2
GA - Gabon	2
GM - Gambi	2
GP - Guadalupe	2
GR - Grecia	2
HT - Haiti	2
IE - Irlanda	2
IL - Israele	2
IQ - Iraq	2
KE - Kenya	2
KY - Cayman, isole	2
LB - Libano	2
LV - Lettonia	2
MA - Marocco	2
MG - Madagascar	2
MR - Mauritania	2
NP - Nepal	2
PE - Perù	2
Totale	1.225

Nome	#
Pembrolizumab in prima linea nel NSCLC: studio pilota in real practice all'Istituto Oncologico Veneto IRCCS per vrificare il rapporto fra tossicità ed esiti	149
Collagen VI sustains cell stemness and chemotherapy resistance in glioblastoma	126
Identification of pyrrolo[3',4':3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas	125
Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities	123
Identification of Homoharringtonine as a potent inhibitor of glioblastoma cell proliferation and migration	120
Histone Deacetylase Inhibitors Impair Glioblastoma Cell Motility and Proliferation	117
Surviving the hunger games: Metabolic reprogramming in medulloblastoma	103
Wnt Signaling in Brain Tumors: A Challenging Therapeutic Target	100
Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities	98
Molecular and functional profiling of chemotolerant cells unveils nucleoside metabolism-dependent vulnerabilities in medulloblastoma	95
Design, synthesis, and biological investigation of selective human carbonic anhydrase II, IX, and XII inhibitors using 7-aryl/heteroaryl triazolopyrimidines bearing a sulfanilamide scaffold	88
Metabolic Adaptation as a Driver of Drug Resistance in Chemotolerant Medulloblastoma Cells	66
Totale	1.310

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	18	0	0	0	0	1	2	2	3	1	5	3	1
2021/2022	19	0	2	1	2	0	3	0	1	0	4	2	4
2022/2023	45	5	0	0	4	5	2	0	4	4	3	17	1
2023/2024	63	0	8	10	8	3	7	7	0	3	1	11	5
2024/2025	496	3	30	8	25	64	18	52	39	22	39	82	114
2025/2026	646	153	70	181	225	17	0	0	0	0	0	0	0
Totale													1.310